First, we examined the proportion of CD34+ MM cells within the total MM cell population (defined as CD45−CD19−CD38+CD138+ cells) using 34-MM samples, consisting of 19 NDMM and 15 relapsed/refractory MM (RRMM) cases. This evidence concerns the gene SDC1 and Miyoshi myopathy.